Anna M. Brynskikh, Ph.D.
Affiliations: | 2013 | Medical Sciences Interdepartmental Area | University of Nebraska Medical Center, Omaha, NE, United States |
Area:
Pharmacy, Medicine and Surgery, Pharmacology, Neuroscience BiologyGoogle:
"Anna Brynskikh"Mean distance: (not calculated yet)
Parents
Sign in to add mentorAlexander V. Kabanov | grad student | 2013 | University of Nebraska Medical Center | |
(Block ionomer of intioxidant enzymes (nanozymes) as therapeutics for neurologic disorders.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Jiang Y, Brynskikh AM, S-Manickam D, et al. (2015) SOD1 nanozyme salvages ischemic brain by locally protecting cerebral vasculature. Journal of Controlled Release : Official Journal of the Controlled Release Society |
Yi X, Manickam DS, Brynskikh A, et al. (2014) Agile delivery of protein therapeutics to CNS. Journal of Controlled Release : Official Journal of the Controlled Release Society. 190: 637-63 |
Manickam DS, Brynskikh AM, Kopanic JL, et al. (2012) Well-defined cross-linked antioxidant nanozymes for treatment of ischemic brain injury. Journal of Controlled Release : Official Journal of the Controlled Release Society. 162: 636-45 |
Klyachko NL, Manickam DS, Brynskikh AM, et al. (2012) Cross-linked antioxidant nanozymes for improved delivery to CNS. Nanomedicine : Nanotechnology, Biology, and Medicine. 8: 119-29 |
Brynskikh AM, Zhao Y, Mosley RL, et al. (2010) Macrophage delivery of therapeutic nanozymes in a murine model of Parkinson's disease. Nanomedicine (London, England). 5: 379-96 |
Batrakova EV, Li S, Brynskikh AM, et al. (2010) Effects of pluronic and doxorubicin on drug uptake, cellular metabolism, apoptosis and tumor inhibition in animal models of MDR cancers. Journal of Controlled Release : Official Journal of the Controlled Release Society. 143: 290-301 |